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NF1 loss disrupts Schwann cell–axonal
interactions: a novel role
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Neurofibromatosis type 1 (NF1) patients develop neurofibromas, tumors of Schwann cell origin, as a result of
loss of the Ras-GAP neurofibromin. In normal nerves, Schwann cells are found tightly associated with axons,
while loss of axonal contact is a frequent and important early event in neurofibroma development. However,
the molecular basis of this physical interaction or how it is disrupted in cancer remains unclear. Here we
show that loss of neurofibromin in Schwann cells is sufficient to disrupt Schwann cell/axonal interactions via
up-regulation of the Ras/Raf/ERK signaling pathway. Importantly, we identify down-regulation of semaphorin
4F (Sema4F) as the molecular mechanism responsible for the Ras-mediated loss of interactions. In heterotypic
cocultures, Sema4F knockdown induced Schwann cell proliferation by relieving axonal contact-inhibitory
signals, providing a mechanism through which loss of axonal contact contributes to tumorigenesis.
Importantly, Sema4F levels were strongly reduced in a panel of human neurofibromas, confirming the
relevance of these findings to the human disease. This work identifies a novel role for the guidance-molecules
semaphorins in the mediation of Schwann cell/axonal interactions, and provides a molecular mechanism by
which heterotypic cell–cell contacts control cell proliferation and suppress tumorigenesis. Finally, it provides
a new approach for the development of therapies for NF1.
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Neurofibromatosis type 1 (NF1) is a common autosomal
dominant genetic disorder of the nervous system that
affects one in 3500 people worldwide (Rubin and Gut-
mann 2005). NF1 patients are heterozygous for loss of
function mutations in the NF1 tumor suppressor gene.
The most distinctive clinical manifestation of the dis-
ease is the development of multiple neurofibromas.
These are highly heterotypic benign tumors of the pe-
ripheral nerve sheath mainly composed of Schwann
cells, fibroblasts, perineurial, inflammatory, and vascu-
lar cells embedded in a rich extracellular matrix (Ric-
cardi 1992). Despite the heterogeneity of neurofibromas,
it is known that Schwann cells are the neoplastic cell
type in these tumors and the limiting step in their trans-
formation is loss of the second NF1 allele (Colman et al.
1995; Serra et al. 2000; Zhu et al. 2002; Rubin and Gut-
mann 2005). Neurofibromas are divided into two sub-
types called dermal and plexiform. The former affect
single terminal nerves and tend to be small and circum-
scribed, whereas the latter develop within multiple fas-
cicles of deep primary nerves and are usually extensive
and diffuse. Although benign in nature, neurofibromas
cause severe pain, disfigurement, and neurological de-
fects. Additionally, while dermal neurofibromas have no
lifetime risk of malignant transformation, plexiform
neurofibromas can progress to highly aggressive sarco-
mas called malignant peripheral nerve sheath tumors
(MPNST) that are almost invariably lethal (Friedman and
Birch 1997).
The NF1 gene encodes the large cytoplasmic protein
neurofibromin (NF1) that contains a Ras GTPase-activat-
ing protein (GAP) domain. GAPs accelerate the conver-
sion of active GTP-bound Ras to its inactive GDP-bound
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form, thereby inactivating Ras signaling. Thus, loss of
neurofibromin results in hyperactivation of Ras and its
downstream effectors (Cichowski and Jacks 2001). El-
evated levels of active Ras have been detected in NF1−/−
and MPNST-derived Schwann cells and shown to be
critical for the maintenance of a transformed phenotype
in these cells (Basu et al. 1992; DeClue et al. 1992; Kim
et al. 1995). However, little is known about how Ras
hyperactivation might affect Schwann cell behavior or
contribute to their transformation.
Schwann cells are the glial cells that wrap and mye-
linate axons in the peripheral nervous system (Jessen and
Mirsky 2005). The behavior of Schwann cells is strictly
under the control of axonal signals both during develop-
ment and in adulthood. Signals from axons regulate
Schwann cell/axonal interactions, provide proliferative
and survival signals, and direct the polarization and dif-
ferentiation programs to either nonmyelinating or my-
elinating phenotypes (Corfas et al. 2004; Michailov et al.
2004; Taveggia et al. 2005; Chan et al. 2006). Moreover,
in the adult, signals from damaged axons can drive a
tightly controlled regenerative program to produce new
Schwann cells to aid nerve repair. In this process,
Schwann cells dedifferentiate to a more progenitor-like
cell type, proliferate dissociated from axons and then re-
differentiate as part of the repair process (Scherer and
Salzar 2001). Interestingly, it appears that these strict
controls have gone awry in neurofibromas, in that tu-
mors are composed of progenitor-like Schwann cells that
have lost the ability to interact with axons and prolifer-
ate abnormally (Zhu et al. 2002; Corfas et al. 2004; Har-
risingh and Lloyd 2004; Rubin and Gutmann 2005).
Importantly, the pathology of neurofibromas and re-
cent mouse models have shown that loss of normal axo-
nal contact is a critical early event in tumor formation,
but the mechanisms responsible are still unknown (Jo-
seph et al. 2008; Wu et al. 2008; Zheng et al. 2008). Here
we show that NF1 loss via Ras/Raf/ERK signaling im-
pairs the ability of Schwann cells to associate with axons
and induce preassociated Schwann cells to dissociate
from axons in primary coculture systems. We identify
down-regulation of the guidance molecule semaphorin
4F (Sema4F) as the molecular mechanism through which
normal Schwann cell/axonal interactions are disrupted
upon Ras hyperactivation. Furthermore, we show that
down-regulation of Sema4F in Schwann cell/axonal co-
cultures results in Schwann cell proliferation, a hall-
mark of tumorigenesis. Importantly, we find that
Sema4F expression is strongly down-regulated in a panel
of human neurofibromas and in MPNST-derived
Schwann cell tumor lines isolated from NF1 patients.
Together, our results identify a novel role for a sema-
phorin, mediating Schwann/cell axonal interactions, and
provide a new molecular mechanism of neurofibroma
formation.
Results
In normal nerves, Schwann cells are exclusively found
associated with axons, whereas the majority of Schwann
cells within neurofibromas have lost axonal contact. To
understand whether this behavior is triggered by Ras hy-
peractivation resulting from NF1 loss, we established a
defined coculture system of primary rat postnatal dorsal
root ganglion neurons (DRGs) and Schwann cells that
recapitulates their normal interactions in the peripheral
nervous system (Wood and Bunge 1975; Kim et al. 1995).
As observed in time-lapse experiments, when normal
Schwann cells are added to DRGs, cell processes make con-
tact with axons, associate and align to them, and eventu-
ally proliferate in response to axonal signals. Importantly,
once established, association is tightly maintained de-
spite extensive remodelling of the axonal network by the
Schwann cells (Supplemental Movie S1). To mimic el-
evated Ras signaling that results from loss of neurofibro-
min, we infected early passage rat Schwann cells (NS)
with a retrovirus that coexpresses oncogenic RasV12 and
GFP (NS-RasV12). Control cells were infected with GFP-
expressing empty vector (NS-Ctl). As expected, NS-
RasV12 cells, but not NS-Ctl cells, rapidly acquired a
refractile morphology typical of Ras transformed cells.
Twenty-four hours post-infection, NS-Ctl and NS-RasV12
cells were seeded onto normal rat DRGs and the inter-
action of GFP-labeled cells with axons studied using
time-lapse microscopy (Supplemental Movies S2, S3).
Whereas the behavior of NS-Ctl cells was indistinguish-
able from uninfected cells, we observed a striking phe-
notype in NS-RasV12 cocultures. As in control cultures,
NS-RasV12 cells extended lamellipodia to establish axo-
nal contacts. However, once in contact with axons, NS-
RasV12 Schwann cells failed to align and associate
tightly to them. Rather, for most cells, the interaction
appeared transient and Schwann cells often dissociated
from an axon and moved to a different axon to initiate
another cycle of loose interaction. We quantified the dis-
ruption to the axonal interactions on fixed cocultures.
Seven hours to 8 h after seeding NS-Ctl or NS-RasV12
cells onto DRGs, the cocultures were fixed and axons
stained for the neurofilament marker RT97. GFP-posi-
tive cells were then categorized on the basis of their po-
sition in relation to axons. We detected three types of
Schwann cell behavior: (1) cells that were fully associ-
ated with axons and displayed tightly aligned cytoplasm
and nucleus to axonal processes in a parallel manner
(associated); (2) cells that made multiple cytoplasmic
contacts with axons but failed to align their cell bodies
and/or nuclei to them (associated but not aligned); (3)
cells that completely lacked axonal contact despite being
in close proximity to axons (nonassociated). For addi-
tional details of the scoring method see Supplemental
Figure S1A. As shown in Figure 1, A and B, whereas the
vast majority of Schwann cells in control cultures asso-
ciated normally to DRGs, ∼50% of NS-RasV12 Schwann
cells displayed aberrant axonal interaction, with a
marked increase in both categories. Thus, oncogenic Ras
signaling in normal Schwann cells is sufficient to disrupt
their association with axons.
To determine whether Ras impairs Schwann cell/axonal
association through the canonical Raf/ERK signaling path-
way, we used primary rat Schwann cells infected with a
Parrinello et al.
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retrovirus encoding an inducible Raf protein(NSRafER).
In this system the Raf-1 kinase domain (Raf) is fused to
the estrogen receptor hormone-binding domain (ER)
(Lloyd et al. 1997) so that Raf kinase is inactive in the
absence of a ligand, but can be rapidly activated upon
addition of the estrogen homolog tamoxifen (Tmx) re-
sulting in sustained ERK activation (Samuels et al. 1993).
We pretreated NSRafER cells with either vehicle (EtOH)
or Tmx for 24 h and then seeded the cells onto DRGs.
Similarly to Ras-infected cultures, addition of Tmx, but
not EtOH, resulted in the acquisition of a “Ras pheno-
type” with cells becoming more refractile. Cocultures
were then monitored by time-lapse microscopy (Supple-
mental Movies S4, S5) or fixed after 7–8 h for immuno-
fluorescence analysis and quantification (Fig. 1C, D). Un-
like EtOH-treated control cells, which rapidly recog-
nized, aligned, and associated with axons, the majority
of Tmx-treated cells only made transient and loose con-
tact with axons, failed to align and associate and fre-
quently moved from axon to axon. Thus, activation of
Raf kinase resulted in a phenotype indistinguishable
from Ras-infected cells. These data indicate that onco-
genic Ras impairs Schwann cell/axonal interactions via
the ERK signaling pathway.
In neurofibromas, Schwann cells are found without as-
sociation with axons most likely as a result of dissociation
of cells that lose NF1 expression. We therefore sought to
address whether Ras/Raf/ERK signaling in associated
Schwann cells can also induce their dissociation from
axons. To do so, we modified the coculture system de-
scribed above to include primary rat perineural fibro-
blasts, as we found these cultures, closely mirror the
organization of the peripheral nerve (Obremski et al.
1993) in that the Schwann cells align and associate very
Figure 1. Oncogenic Ras/Raf impairs Schwann cell–axonal interactions. (A–D) Primary rat DRG–Schwann cells association assays.
(E,F) Primary rat DRG–Fibroblast–Schwann cell dissociation assay. (A) Immunofluorescence staining for neurofilament marker RT97
(red) and GFP (green) of NS-Ctl (Ctl) or NS-RasV12 (RasV12) infected Schwann cells. Nuclei are counterstained with Hoechst. (C,E)
Immunofluorescence staining for RT97 (red) and Schwann cell marker S100 (green) of NSRafER cocultured with DRGs (C) or DRG
and fibroblasts (E) in the presence of vehicle (EtOH) or tamoxifen (Tmx). Arrow in E indicates an example of a dissociated Schwann
cell. (B,D,F) Quantification of Schwann cell–axonal interactions. Graphs show the percentage of Schwann cells in the cultures that fail
to associate (black) or associate but do not align (gray) with axons. Data represent mean ± SE of duplicate cultures (n > 400 cells;
asterisk indicates statistical significance and P values are shown). For each data set, a representative experiment of three independent
repeats that gave similar results is shown.
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tightly with bundles of axons, making this an ideal sys-
tem to detect changes in established Schwann cell–axo-
nal interactions. We set up cocultures of DRGs, fibro-
blasts, and NSRafER cells in defined medium. Within 3
d, reorganization of cultures could be detected, with dis-
crete bundling of the axons that became ensheathed by
groups of Schwann cells. Fibroblasts remained under the
axon–Schwann cell network and between axonal
bundles. Next, we treated the cocultures with EtOH or
Tmx for 24–28 h and analyzed the cultures by time-lapse
microscopy and immunostaining. As shown in Supple-
mental Figure S1, B and C, activation of Raf kinase re-
sulted in the dissociation of a large proportion of the
Schwann cells. Immunofluorescence analysis confirmed
this behavior (Fig. 1E,F). While EtOH-treated cultures
displayed axon bundles ensheathed by cords of parallel
Schwann cells, Tmx-treated cultures contained many
Schwann cells that had lost proper alignment and/or had
dissociated completely from the axons. In these cultures
both groups of nonassociated and associated but not
aligned cells increased dramatically in Tmx cultures
compared with EtOH controls. Thus, activation of the
Ras/Raf/ERK signaling pathway is sufficient to induce
the dissociation of Schwann cells from axons.
Together, our results strongly suggest that elevated
Ras signaling, due to loss of neurofibromin, is respon-
sible for the disruption of Schwann cell/axonal interac-
tions observed in neurofibromas. However, neurofibro-
min has also been linked to Ras-independent signaling
pathways. Moreover, overexpression of oncogenic Ras/
Raf and NF1 loss might trigger different levels of ERK
activation and therefore not be directly comparable. To
assess whether NF1 loss interferes with Schwann cell/
axonal interactions, we took two parallel approaches.
First, we used RNAi to down-regulate NF1 expression in
rat Schwann cells. We transiently transfected siRNA to
Nf1 into primary rat Schwann cells and confirmed the
efficacy of the knockdown by quantitave RT–PCR and
Western blotting (Supplemental Fig. S2B,H). Forty-eight
hours post-transfection NF1 knockdown cells, but not
control cells, had acquired a refractile morphology, typi-
cal of Ras-overexpressing cells (Supplemental Fig. S2A).
Both cell types were seeded onto rat DRGs and analyzed
by time-lapse microscopy and quantification of immu-
nostained cultures as above. Similarly to Ras/Raf over-
expression, down-regulation of NF1 in rat Schwann cells
disrupted Schwann cell/axonal interactions and in fixed
cultures resulted in a large increase in both groups of
cells with deregulated association (Fig. 2A,B). Second, we
isolated primary Schwann cells from Nf1flox/flox mice
that carry conditional alleles at the Nf1 locus (Zhu et al.
2002). Recombination of the Nf1 gene was induced by
infecting the cultures with adenoviruses constructed to
express Cre recombinase. Control cultures were infected
with the same adenoviral vectors encoding GFP. In ad-
dition, we infected wild-type primary Schwann cells with
both adenoviruses to control for any Cre-mediated tox-
icity. Infection conditions were optimized to achieve
maximal infection efficiency as judged by the percentage
of GFP-positive cells (>95%) and minimal cell death.
Recombination of the Nf1flox alleles and resultant abla-
tion of NF1 expression was confirmed by PCR (data not
shown) and Western blotting (Fig. 2H). Four-day to 6-d
post-infection Schwann cells transduced with adeno-
GFP (GFP) or adeno-Cre (CRE) were seeded onto rat
DRGs and their association scored by immunofluores-
cence analysis. No difference in axonal association could
be detected between GFP and CRE-infected wild-type
cells (Supplemental Fig. S2C,D). In contrast, as in the rat
cocultures, Nf1 recombination induced a dramatic change
in Schwann cell/axonal interactions compared with con-
trols (Fig. 2C,D). Whereas, the vast majority of GFP
Schwann cells made contact and aligned with axons,
many CRE cells showed aberrant axonal interactions
with a marked increase in nonassociated cells and a
more modest increase in the associated but not aligned
group. This was in contrast to rat association cultures
where the majority of the Schwann cells remained asso-
ciated but were not properly aligned. We think this dis-
crepancy might be attributable to less efficient basal as-
sociation of murine cells to rat axons. Nonetheless, the
behavior of GFP and CRE cells on axons was markedly
different. To address whether NF1 loss also triggers dis-
sociation of Schwann cells from axons, we established
orthotypic cultures of Schwann cells, neurons, and fibro-
blasts isolated from embryonic Nf1flox/flox DRGs. Within
7 d, these cultures underwent a profound reorganization
to generate axonal bundles ensheathed by Schwann cells
that sat on top of a layer of fibroblasts (Fig. 2E). Impor-
tantly, the cellular organization seen in this system
closely resembles the rat dissociation assay described
above (Fig. 1E), and is thought to mimic peripheral nerve
structure (Rosenbaum et al. 1999). Indeed, upon addition
of differentiation medium, robust myelination could be
achieved at this stage (data not shown). As above, Nf1flox
recombination was induced using adenoviral-mediated
delivery of Cre recombinase. For these experiments we
optimized the culture conditions to achieve maximal in-
fection of Schwann cells and minimal cross-infection of
neurons and fibroblasts, as judged by GFP fluorescence.
Strikingly, within 3–6 d from infection we observed pro-
nounced dissociation of CRE, but not GFP, Schwann
cells from axons. Thus, similarly to oncogenic Ras/Raf
overexpression, NF1 loss disrupts Schwann cell/axonal
interactions, most likely as a result of Ras hyperactiva-
tion (Fig. 2E,F).
To test this more directly, we repeated the Nf1flox/flox
association studies in the presence of specific inhibitors
of downstream effectors of Ras signaling. As shown in
Figure 2G, the MEK inhibitor UO126, but not the PI3
Kinase inhibitor LY294002, completely abolished the as-
sociation defect of CRE Schwann cells. Efficacy of the
inhibitors was confirmed by Western blotting (data not
shown). We conclude that in neurofibromas, loss of neu-
rofibromin in Schwann cells induces their dissociation
from axons through Ras/Raf/ERK signaling. Our data also
indicate that rat NSRafER cells can be used to model
Nf1−/− Schwann cell behavior.
The molecules that mediate Schwann cell/axonal in-
teractions are poorly defined; therefore, to address the
Parrinello et al.
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molecular mechanisms through which Ras/Raf/ERK sig-
naling might disrupt Schwann cell/axonal interactions
in NF1 we took a candidate approach. We used microar-
ray analysis to identify adhesion molecules whose ex-
pression changed following Raf activation. We compared
RNA of NSRafER cells treated with EtOH or Tmx for
Figure 2. NF1 loss impairs Schwann cell–axonal interactions through the Raf/ERK pathway. (A,B) Primary rat DRG–Schwann cells
association assays. (C,D,G) Primary rat DRG–Nf1flox/flox mouse Schwann cell association assay. (E,F) Orthotypic Nf1flox/flox DRG–
fibroblast–Schwann cell dissociation assay. (A) Immunofluorescence staining for RT97 (red) and Schwann cell marker S100 (green) of
NS cells transfected with scrambled or one of two independent siRNA oligos to NF1 cocultured with DRGs. Nuclei are counterstained
with Hoechst. (C,E) Immunofluorescence staining for Schwann cell marker p75NGFR (green) and RT97 (red) of Adeno-GFP-infected
(GFP) or Adeno-Cre-infected (CRE) cultures. (B,D,F) Quantification of Schwann cell/axonal interactions. Shown is one representative
experiment of three that gave similar results. Bars represent mean ± SE of duplicate cultures (n > 400 cells). Asterisk indicates
statistical significance as shown by P value. (G) Quantification of DRG–Nf1 flox/flox Schwann cells association assays performed in the
absence (left GFP and CRE bars) or presence (middle and right GFP and CRE bars) of specific inhibitors of Ras signaling (U0126 15 µM,
LY294002 20 µM). (H) Western analysis of neurofibromin (NF1) knockdown in rat NS (left) and mouse NS cells (right).
Schwann cell–axonal interactions in NF1
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24 h in defined serum-free culture conditions. One-thou-
sand-fifty-seven probe sets were differentially down-
regulated by Raf activation, of which 379 were consid-
ered to be strongly down-regulated (>−3.5-fold). We se-
lected six strongly down-regulated candidates based on
their known function and cell surface expression (none
of the up-regulated genes were considered good candi-
dates). We validated the microarray results by quantita-
tive RT–PCR in one independent set of EtOH- and Tmx-
treated NSRafER cultures and two independent sets of
GFP- and CRE-infected murine Nf1flox/flox Schwann cells
(Supplemental Fig. S3A). We reasoned that molecules
down-regulated in both systems would be likely media-
tors of the Ras-induced phenotype. Of the six candidates,
only four (Semaphorin 4F,  catenin-like 1, cadherin 13,
and protocadherin 20) were significantly down-regulated
upon NF1 loss (Fig. 3A) and Raf activation (Supplemental
Fig. S3A).
To test whether the down-regulation of any of these
genes was responsible for the Ras-induced disruption of
Schwann cell/axonal interactions, we used RNAi to spe-
cifically down-regulate their expression. siRNA oligos
for each of the genes tested were transfected into normal
rat Schwann cells (NS) and efficacy of the knockdown
confirmed by quantitative RT–PCR (Supplemental Fig.
S3B). Thirty-six-hour post-transfection NS cells were
seeded onto rat DRGs and 7–8 h later cultures were fixed
and quantified. Down-regulation of cadherin 13, pro-
tocadherin 20, or -catenin-like 1 did not affect Schwann
cell association to axons, suggesting that these mol-
ecules are not involved in normal Schwann cell/axonal
interactions and do not mediate the Ras phenotype. In
contrast, knockdown of semaphorin 4F (Sema4F) dra-
matically disrupted axonal association and alignment of
NS (Fig. 3B,C). Strikingly, the effect of Sema4F siRNA
closely mirrored the disregulation of Schwann cell/axo-
nal interactions observed in Ras/Raf cocultures (Fig. 1).
To rule out off-target effects, we repeated the same assay
using two independent siRNA oligos (Fig. 3D) and found
comparable disruption of Schwann cell/axonal associa-
tion. Moreover, using site-directed mutagenesis, we gen-
erated an RNAi-resistant form of Sema4F (Sema4F*) and
confirmed resistance to RNAi knockdown by quantita-
tive RT–PCR (data not shown). Importantly, transient
transfection of NS cells with Sema4F* prior to Sema4F
knockdown, fully rescued the association defect, con-
firming the specificity of the Sema4F phenotype (Supple-
mental Fig. S3C). Finally, quantitative RT–PCR showed
that expression levels of other semaphorins present in
Schwann cells remain unchanged upon transfection with
Sema4F siRNA (Fig. 3E).
Our data suggest that NF1 loss disrupts Schwann cell/
axonal interactions through Ras/Raf/ERK-mediated
Sema4F down-regulation. To confirm this we measured
Sema4F levels in rat Schwann cells upon siRNA-medi-
ated NF1 down-regulation. As shown in Supplemental
Figure S4A, we detected a decrease in Sema4F levels
comparable with that observed in the NSRafER and
Nf1flox/flox systems. Importantly, Sema4F down-regula-
tion could be reverted by a MEK, but not a PI3K, mTOR,
or PKA inhibitor or a PKA activator (Supplemental Fig.
S4B), clearly demonstrating that the down-regulation is
mediated by the MEK pathway and is independent of
other signaling pathways reported to be downstream
from loss of NF1. To confirm the role of MEK, we mea-
sured Sema4F RNA levels in NSRafER cells following
Raf activation in the presence or absence of two highly
specific MEK inhibitors UO126 and PD184352 (Bain et
al. 2007). As shown in Supplemental Figure S4C, both
inhibitors completely blocked Raf-mediated Sema4F
down-regulation. Additionally, we infected NS cells
with either control (Ctl) retroviruses or retroviruses car-
rying oncogenic Ras (RasV12) or a constitutively active
form of MEK (MEK-CA) (Cowley et al. 1994) and, after
drug selection, measured Sema4F levels in the cultures
by quantitative RT–PCR (Supplemental Fig. S4E). As ex-
pected, both RasV12 and MEK-CA overexpression dra-
matically reduced Sema4F levels.
We showed that loss of semaphorin 4F is sufficient to
disrupt Schwann cell/axonal interactions. To address
whether it is solely responsible for the NF1-mediated
disruption we asked whether overexpression of Sema4F
in Schwann cells would be sufficient to rescue the dis-
ruption of axonal association triggered by NF1 loss. We
transiently transfected NS with control vector alone
(Ctl) or vector encoding full-length rat Sema4F. Both cell
types were cotransfected with a vector encoding GFP to
label transfected cells and expression was confirmed us-
ing RT–PCR (data not shown). The next day RNAi was
performed using either Scr or NF1 oligos and 36 h later
cells were seeded onto DRGs and GFP-positive cells
scored. As expected, both Ctl and Sema4F cells trans-
fected with Scr siRNA associated normally with axons,
whereas NF1 loss in Ctl cells (Ctl NF1) impaired
Schwann cell/axonal interactions. In striking contrast,
the association defect resulting from NF1 loss was
largely rescued in Sema4F cells (Sema4F NF1) (Fig. 3F).
Similar results were obtained in NSRafER using the
same strategy (Supplemental Fig. S5) Thus, our data
strongly indicate that NF1 loss disrupts Schwann cell/
axonal interactions through specific Ras/Raf/ERK-medi-
ated down-regulation of Sema4F. They also show that
Sema4F is an important mediator of the association of
normal Schwann cells to axons in the peripheral nerve.
Although little is known about Sema4F, expression
studies of this putative membrane-bound member of the
semaphorin family, have detected expression postnatally
in many tissues with highest levels in the brain (Encinas
et al. 1999), suggesting that it may play an important role
in the maintenance of adult nervous tissue. Our results
indicate that Sema4F might also be critical in the adult
peripheral nerve. To address Sema4F expression in vivo
in the peripheral nerve, we extracted total RNA from
sciatic nerves isolated from postnatal day 0, 7, 14, 21,
and 60 (P0, P7, P14, P21, and P60) rats and performed
quantitative RT–PCR. As shown in Supplemental Figure
S6A, Sema4F expression was detected at all stages. Next,
we compared levels of Sema4F in P7 sciatic nerve, first
passage P7 Schwann cells cultured in defined serum-free
medium for 48 h and first passage P7 perineurial fibro-
Parrinello et al.
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blasts (Supplemental Fig. S6B). Sema4F levels were as
high in Schwann cells as in the nerve, but almost unde-
tectable in fibroblasts, indicating that in the postnatal
nerve, where Schwann cell/axonal interactions are fully
established, Schwann cells express Sema4F. This finding
also confirms that Sema4F expression in cultured Schwann
Figure 3. Down-regulation of Semaphorin 4F mediates the disruption of Schwann cell/axonal interactions induced by loss of NF1. (A)
Quantitative RT–PCR analysis of mRNA expression levels of indicated proteins in purified Nf1flox/flox Schwann cells infected with
Adeno-GFP (GFP, dark gray bars) or Adeno-Cre (CRE, light gray bars). (B) Quantification of rat DRG–Schwann cells association assay.
NS were transfected with scrambled siRNA sequences (Scr) or siRNA sequences to cadherin-13 (Cdh-13), -catenin like 1 (Ctnnal),
semaphorin 4F (Sema4F), and protocadherin 20 (Pcad20) and seeded onto DRGs. Only Sema4F siRNA disrupted axonal association.
Shown is the mean ± SE of duplicate cultures. (n > 400 cells). Asterisk indicates statistical significance as shown by P value. Data are
representative of one of three independent experiments with similar results. (C) Representative immunofluorescence staining of DRGs
cocultured with NS cells transfected with scrambled (scr) or semaphorin 4F (Sema4F) siRNAs. Schwann cells are labeled with
anti-S100 antibody and axons are labeled with anti-RT97 antibody. (D) Quantification of Schwann cell–axonal interactions in DRG
association assays performed with NS cells transfected with siRNA to a scrambled (scr) or two independent semaphorin 4F sequences
(Sema4F RNAi-1 and -2) or their combination (Sema4F RNAi 1 + 2). (E) Quantitative RT–PCR for Schwann cell-expressed semaphorins
following transfection with scrambled (scr) or semaphorin 4F (Sema4F) siRNAs. (F) Quantification of Schwann cell/axonal interactions
in DRG association assays performed with NS cells cotransfected with a GFP-encoding vector and either empty vector (Ctl) or Sema4F
encoding vector and subsequently transfected with either Scr or NF1 siRNA oligos as indicated. Only GFP-positive cells were scored.
Shown is the mean ± SE of triplicate cultures (n > 600 cells). Asterisks indicate statistical significance. Shown is one representative
experiment of three that gave similar results.
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cells is not the result of prolonged tissue culture or ex-
posure to serum, but rather reflects their phenotype in
vivo. To begin to understand the function of Sema4F
in the peripheral nerve, we first sought to confirm mem-
brane localization in Schwann cells. We transiently ex-
pressed GFP-tagged Sema4F (Sema4F-GFP) or a control
GFP (Ctl-GFP) vector in NS, performed subcellular frac-
tionation and analyzed expression by Western blotting
using a GFP antibody. As expected, Sema4F-GFP was
only present in the membrane fraction of transfected
cells. Importantly, the vast majority of GFP was detected
in the cytosolic fraction, confirming successful fraction-
ation (Supplemental Fig. S6A). Moreover, in an extracel-
lular biotinylation assay, this fusion protein could be
labeled with biotin, confirming plasma-membrane local-
ization (data not shown). We then asked whether
Sema4F in the Schwann cell plasma membrane localizes
to sites of axonal contact in cocultures. We cocultured
NS cells, transfected with Sema4F-GFP, with rat DRGs
for 24 h to allow complete association and alignment and
performed immunofluorescence analysis. As shown in
Supplemental Figure S6B, we detected lines of GFP fluo-
rescence that localized alongside axons in most Schwann
cells. These results suggest an adhesive role for Sema4F
in Schwann cell/axonal interactions. However, trans-
membrane semaphorins, with intracellular domains,
have been purported to reverse signal into the expressing
cell. Sema4F contains a relatively large intracellular re-
gion containing a PDZ-binding domain (Kruger et al.
2005). To address whether reverse signaling through
Sema4F is involved in meditating Schwann cell/axonal
interactions, we generated a truncated form of Sema4F
lacking the entire intracellular domain (Sema4FC) and
asked whether overexpression of Sema4FC in Nf1
knockdown Schwann cells would be sufficient to rescue
the axonal association defect as described above for the
full-length construct. Expression of the Sema4FC con-
struct was confirmed by quantitatice RT–PCR (data not
shown). As shown in Figure 3F, Sema4FC rescued axo-
nal association as efficiently as full-length Sema4F, in-
dicating that reverse signaling, via the intracellular do-
main, is not required for Schwann cell/axonal interaction.
In adult nerves, signals from axons are proposed to
maintain Schwann cells in a differentiated, quiescent
state (Jessen and Mirsky 2005). Therefore, it is conceiv-
able that disruption of Schwann cell/axonal contacts re-
sults in increased Schwann cell proliferation, which is a
hallmark of tumorigenesis. To test this more directly,
we cocultured rat NS and DRGs in defined medium to
allow NS to associate to axons and proliferate exclu-
sively in response to axonal signals as reported (Wood
and Bunge 1975). After 5 d, once NS proliferation was
mostly exhausted and cells fully occupied the axonal
network, the culture medium was changed to either
fresh defined medium or defined medium supplemented
with serum and BrdU incorporation measured over 8 h
the following day. As shown in Figure 4A, in the absence
of serum minimal proliferation of NS cells on axons was
observed, as expected. In contrast, upon serum stimula-
tion of the cocultures, NS that were not associated with
axons, at the edge of the coverslip, proliferated (40%–
50%), whereas those on axons were strongly cell cycle-
Figure 4. Down-regulation of Semaphorin 4F re-
sults in Schwann cell proliferation. (A) BrdU incor-
poration of NS cells cocultured with DRGs. BrdU-
positive cells in contact with axons (on) and at the
periphery of the DRG with no axonal contact (off)
were counted in the absence or presence of serum as
indicated. Representative of three that gave similar
results. Shown is the mean ± SE of triplicate cover-
slips. (B,D) BrdU incorporation of NS cells trans-
fected with siRNAs to a scrambled (Scr, black) or
semaphorin 4F sequence (Sema4F, gray). Upon se-
rum stimulation, percentage of BrdU labeling of
cells in contact with axons (B) and without axonal
contact (D) was calculated. Representative experi-
ment of three that gave similar results. Shown is the
mean ± SE of triplicate coverslips. Shown are the re-
sults using the mixture of two siRNAs to Sema4F.
Similar results were obtained with each siRNA in-
dividually. (C) Representative image of results quan-
tified in B. (Red) axons; (green) BrdU incorporation;
(blue) Hoechst.
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inhibited (∼1%). Importantly, this effect was not depen-
dent on cell density, as parallel NS cultures at similar
high density, in the absence of axons, were able to re-enter
the cell cycle upon serum addition (data not shown). These
results suggest that once Schwann cell/axonal interac-
tions are fully established, axonal signals maintain
Schwann cells in a quiescent state in which they are
resistant to environmental mitogenic cues. We then
asked whether Sema4F down-regulation might increase
Schwann cell proliferation. We seeded NS cells onto
axons as above and 4 d later transfected the cultures with
scrambled siRNA oligos (Scr) or two independent oligos
to Sema4F used either separately or in combination.
Strikingly, in all cases Sema4F down-regulation resulted
in a sixfold to sevenfold increase in BrdU labeling of cells
on axons, following serum addition (Fig. 4B,C; data not
shown). Importantly, no difference in proliferation could
be detected between Scr and Sema4F cells that were not
in contact with axons, confirming that the effect on
Schwann cell proliferation is indirect (Fig. 4D). Similar
results were obtained using Schwann cells engineered to
constitutively express shRNAs to Sema4F, confirming
that the increase in proliferation results from Schwann
cell intrinsic loss of Sema4F (Supplemental Fig. S7).
Thus, our results identify a novel Ras-mediated mecha-
nistic link between NF1 loss and tumorigenesis: Sema4F
down-regulation leading to loss of heterotypic contact
inhibition of proliferation.
To assess how our findings relate to tumor develop-
ment in humans in vivo, we obtained RNA from sec-
tions of a panel of human neurofibromas from NF1 pa-
tients, one schwannoma, and two normal nerve tissue
samples, and measured Sema4F levels by quantitative
RT–PCR (Fig. 5A). Remarkably, whereas Sema4F was
present in normal tissue and in the schwannoma at simi-
lar levels, little to no expression was detectable in all the
neurofibromas analyzed. In addition, we also tested
Sema4F levels in normal early passage primary human
Schwann cells and a panel of human MPNST-derived
tumor cell lines of Schwann cell origin. We chose three
cell lines (NF88-3, NF90-8, and ST88-14) that were
shown to be devoid of functional neurofibromin and to
have elevated Ras-GTP levels (Basu et al. 1992; DeClue
et al. 1992). As expected, all tumor lines failed to asso-
ciate and align with axons like normal human Schwann
cell controls in our coculture system (Fig. 5B). However,
remarkably, two of the three cell lines (NF90-8 and
ST88-14) still recognized and asociated to some extent
with axons, displaying the disrupted interactions of Ras-
overexpressing Schwann cells. All cells were cultured
under the same conditions prior to RNA purification and
Sema4F levels were tested by quantitative RT–PCR. As
shown in Figure 5C, we found Sema4F to be expressed in
normal human Schwann cells and to be strongly down-
regulated in all tumor lines analyzed.
Discussion
The development and maintenance of a tissue is, by ne-
cessity, a tightly regulated process, involving cell-autono-
mous controls as well as heterotypic cell signaling that
ensure the correct balance and distribution of cells
within a tissue. A classic example of heterotypic cell
regulation is seen within peripheral nerves where sur-
vival, mitogenic, and differentiation signals, provided by
axons, regulate each stage of the development of the
Figure 5. Semaphorin 4F expression is down-regulated in hu-
man neurofibromas and MPNST-derived human tumor cell
lines. (A,C) Quantitative RT–PCR analysis of semaphorin 4F
expression normalized to GAPDH. (A) RNA levels in sections of
normal human nerve tissue (N1, N2), human schwannoma (S),
human dermal (T1, T2), and plexiform neurofibromas (T3–T6).
(C) Expression in human Schwann cells (hSC) and three tumor
cell lines (NF88-3, NF90-8, and ST88-14) of Schwann cell origin
cultured under the same conditions. (B) Immunofluorescence
staining for neurofilament marker RT97 and p75NGFR (hSC) or
fluorescence of tumor cells prelabeled with a vital cell dye
(NF88-3, NF90-8, and ST88-14).
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Schwann cells that eventually enwrap them. In the
adult, signals from the axons maintain the Schwann
cells out of the cell cycle in a specialized, differentiated
state that ensures the survival and efficient functioning
of peripheral nerves. However, while seemingly a stable
structure, the peripheral nerve is regenerative; upon in-
jury, loss of axonal contact and signals resulting from
degeneration of damaged axons, triggers Schwann cell
dedifferentiation to a proliferative progenitor-like cell to
promote nerve repair. Following successful axonal re-
growth, signals from axons direct the redifferentiation of
Schwann cells to reconstitute a fully functional nerve.
In this regard, Schwann cells are an especially inter-
esting cell type in that a stem cell population does not
persist in postnatal animals. Instead quiescent, special-
ized, differentiated cells, dedifferentiate, and proliferate
to generate new cells. This behavior, coupled with the
observation that the majority of the cells within neuro-
fibromas have a Schwann cell phenotype, led to specu-
lation that differentiated Schwann cells are the cell of
origin of this tumor type. Recent mouse models have
largely confirmed these ideas. Embryonic neural crest
cells, from which Schwann cells derive, have been con-
firmed not to persist postnatally and Nf1 loss does not
increase the persistence of these cells. Instead, these
studies have implicated mature, nonmyelinating Schwann
cells as the cell of origin of these tumors. (Joseph et al.
2008; Wu et al. 2008; Zheng et al. 2008). Intriguingly, it
appears that the timing of the loss of Nf1 is important,
needing to occur at a specific point during development.
Whether this has relevance to the human disease is not
clear and further studies are obviously required. How-
ever, consistent with the human disease, the earliest vis-
ible event in neurofibroma formation is loss of Schwann
cell/axonal contacts, arguing that loss of these contacts
is an important step in the etiology of the disease.
Using cell culture models that closely resemble the
complex structure of peripheral nerves, we now show
that increased Ras/Raf/ERK signaling is sufficient to dis-
rupt Schwann cell–axonal interactions. Rat Schwann
cells engineered to express oncogenic Ras or Raf or to
down-regulate NF1 expression and recombined Nf1flox/flox
mouse Schwann cells failed to associate and align with
axons in primary coculture systems. This phenotype
could be specifically reversed by treatment of Nf1−/−
cells with the MEK inhibitor UO126. Moreover, acute
activation of Raf kinase or loss of NF1 was sufficient to
induce the dissociation of Schwann cells from axons in
established primary DRG–fibroblast–Schwann cell co-
cultures. Importantly, our findings that ERK signaling,
resulting from NF1 loss, in Schwann cells, is sufficient
to induce the dissociation of Schwann cells from axons,
clearly demonstrates that these results are not the result
of overexpression but are relevant to neurofibroma for-
mation, in which Schwann cells that have lost NF1 are
found dissociated from axons. It is also of note that, fol-
lowing nerve injury, myelinating Schwann cells exhibit
high levels of ERK activation for up to 3 d (Harrisingh et
al. 2004). These levels might also be predicted to disrupt
the tight alignment of Schwann cells with axons, and
may be important for the normal dedifferentiation and
repair process.
Our findings are in contrast however, with those of
Kim et al. (1995), who reported that Ras-overexpressing
and NF1−/− Schwann cells adhere normally to axons. We
believe that the differences in the results can be attrib-
uted to the dynamic nature of Schwann cell/axonal in-
teractions in these cultures. Our time-lapse experiments
show that activation of Ras signaling does not abolish
the ability of Schwann cells to recognize axons alto-
gether. Rather, maintenance of axonal interactions and
proper alignment to axons are impaired and cells fre-
quently move from axon to axon. Therefore, at any given
time a proportion of Schwann cells in the cocultures are
found associated to axons, and could give misleading re-
sults in fixed cultures.
Very little is known about how normal Schwann cell/
axonal interactions are mediated, although a number of
adhesion molecules have been reported to have a role
(Wanner and Wood 2002; Corfas et al. 2004; Itoh et al.
2005). Here, we identified Sema4F as a mediator of nor-
mal Schwann cell/axonal interactions and showed that
down-regulation of Sema4F is a major molecular media-
tor of the Ras-induced disruption of this process. Sema-
phorins are a large family of secreted and membrane-
associated proteins most commonly associated with a
role in axon guidance (Kruger et al. 2005). Sema4F is a
transmembrane family member whose function is
poorly understood. Unlike many semaphorins, which are
predominantly expressed in development, Sema4F ex-
pression is retained postnatally in many tissues, includ-
ing the central nervous system (Encinas et al. 1999). The
most extensively studied biological function of sema-
phorins is their role in guiding axons to their targets in
the developing nervous system by providing repulsive
signals. However, more recently, it has been reported
that semaphorins can also act as axonal attractants and
mediate adhesive signals in a variety of tissues, both in
development and adulthood (Wong et al. 1999; Masuda
et al. 2004; Kruger et al. 2005; Casazza et al. 2007). More-
over, changes in semaphorin expression in adult tissues
have been linked to pathological processes, including
cancer and neurodegenerative disease (Kruger et al.
2005). Here, we identified a novel postnatal function for
a semaphorin—as an important mediator of axonal/glial
interactions—in that its expression in Schwann cells is
required for the proper association and alignment of
Schwann cells to axons. Importantly, we detected
Sema4F in adult peripheral nerves where Schwann cells
accounted for most of Sema4F expression. This is con-
sistent with a recent study that reported Sema4F expres-
sion in glial cells (Cohen et al. 2003). Moreover, in cul-
tured Schwann cells, Sema4F was detected at the plasma
membrane and enriched at sites of axonal contact. Inter-
estingly, our results with the Sema4FC construct indi-
cate a predominantly adhesive role for this semaphorin.
However, at present, we cannot rule out that signaling
into the Schwann cell through an alternate mechanisms
(i.e., a coreceptor) might be required for Schwann cell/
axonal interactions, and future studies will be needed to
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address this in greater detail. Thus, we envision that in
the adult peripheral nerve, Sema4F might act in concert
with other known adhesion molecules (e.g., N-cadherin,
L1) to mediate and stabilize Schwann cell–axonal inter-
actions. Interestingly, glial cells have been reported both
to be important for the outgrowth of axons during devel-
opment and to act as cellular conduits to facilitate axo-
nal regrowth following nerve injury. In vitro studies have
also shown that glial cells are preferential substrates for
axons (Wanner et al. 2006). It will be of great interest to
explore the role of semaphorins in these processes.
Sema4F was strongly down-regulated upon activation
of Ras, Raf kinase, and loss of NF1 (through the MEK
pathway) in cultured primary Schwann cells. Moreover,
down-regulation of Sema4F, to those levels, by siRNA in
normal Schwann cells was sufficient to disrupt interac-
tions with axons to a similar extent as Ras hyperactiva-
tion and restoring Sema4F levels in NF1-knockdown
cells ameliorated axonal association. Intriguingly, Sema4F
levels in Schwann cells appeared to be down-regulated
only in response to a seemingly “pathological” ERK sig-
nal, such as that found in cancer. Hence, the more pro-
genitor-like Schwann cells that proliferate upon removal
from the nerve in culture (and are found following nerve
injury in vivo), express high levels of Sema4F and asso-
ciate tightly with axons despite ERK activation as a re-
sult of normal mitogenic signaling. In contrast, sus-
tained ERK signaling as a result of oncogenic Ras signal-
ing strongly down-regulates Sema4F levels, resulting in
the dissociation of Schwann cells from axons. Currently,
the physiological significance of this pathway is un-
known (although it is tempting to speculate that it may
have a role early in the nerve repair process when levels
of ERK signaling in Schwann cells are very high). What is
clear, however, is that in pathological situations that re-
sult in high levels of ERK activation, Sema4F expression
is down-regulated leading to a disruption in Schwann
cell/axonal interactions. Consistent with this, we found
that Sema4F levels were strongly down-regulated in a
panel of human neurofibromas and MPNST-derived hu-
man tumor cell lines, indicative of this process having a
role in human tumor formation, resulting from Ras ac-
tivation in human Schwann cells.
How might Ras/Raf/ERK-mediated down-regulation
of Sema4F contribute to neurofibroma development in
NF1 patients? Both in human tumors and in neurofibro-
mas that form in mouse models, the majority of
Schwann cells are found dissociated from axons, suggest-
ing that loss of axonal contact is a critical step in the
etiology of these lesions. We showed here that axonal
contact is crucial for maintaining Schwann cells in a
quiescent state in which they are resistant to environ-
mental mitogenic cues. Importantly, down-regulation of
Sema4F in Schwann cell–DRG cocultures, but not in
Schwann cell monocultures, resulted in elevated Schwann
cell proliferation. This suggests that Sema4F loss does not
affect the cell cycle directly, but rather promotes prolif-
eration indirectly by overriding heterotypic contact-in-
hibitory axonal signals. This disruption in the Schwann
cell microenvironment is likely to promote tumorigen-
esis, as it renders Schwann cells more responsive to en-
vironmental proliferative cues. Interestingly, genetic
evidence in the Nf1flox mouse model has shown that
neurofibroma development can be contingent upon ex-
posure of Nf1−/− Schwann cells to an Nf1+/− tissue envi-
ronment (Zhu et al. 2002). This has led to the specula-
tion that the haploinsufficient Nf1 environment might
foster tumorigenesis by providing factors that promote
Schwann cell proliferation. Thus, we think that in neu-
rofibroma formation, proproliferative signals from the
Nf1+/− microenvironment synergize with Ras-induced
loss of axonal contact to drive the proliferation of Nf1−/−
Schwann cells.
Some of the transformed phenotypes of Nf1−/−
Schwann cells have been linked previously to increased
Ras signaling, and were shown to be reversed by Ras
inhibitors (Kim et al. 1997). Here, we uncovered a novel
Ras-induced tumorigenic property of Nf1−/− Schwann
cells: Loss of axonal interactions and treatment of Nf1−/−
Schwann cells with the MEK inhibitor UO126 re-estab-
lished normal axonal interactions. Thus, our data cor-
roborate the idea that therapeutics aimed at reducing Ras
signaling might be useful for the treatment of neurofi-
bromas. Additionally, our findings provide novel targets
and a distinct approach for the development of therapeu-
tics for the treatment of NF1.
Materials and methods
Mice and genotyping
NF1flox/+ animals from Luis Parada were backcrossed to obtain
homozygous NF1flox/flox transgenic animals. Genotyping and as-
sessment of Cre-mediated recombination were performed using
sensitive three-oligonucleotide primer PCR assays as described
(Zhu et al. 2002). All animal work was carried out in accordance
to the guidelines and regulations of the Home Office.
Cell culture
Primary rat Schwann cells and fibroblasts derived from P7
Sprague-Dawley rat sciatic nerve were isolated and subcultured
as previously reported (Mathon et al. 2001). NSRafER cells are
as described previously (Lloyd et al. 1997). To prepare primary
mouse Schwann cells, P2–P4 sciatic and brachial nerves were
dissected from Nf1flox/flox animals, desheathed, and treated with
a mixture of collagenase (2 mg/mL) and trypsin (1.25 mg/mL) for
35 min at 37°C. The tissue was then gently dissociated through
a plastic pipette tip, and cells were centrifuged and plated on
poly-L-lysine and laminin coated dishes in DMEM containing
5% horse serum (Invitrogen) and arabinosylcytosine (Sigma)
to remove contaminating fibroblasts. After 48–72 h, culture
medium was changed to growth medium consisting of G5-
supplemented neurobasal medium containing 3% horse serum
(Invitrogen), recombinant GGF (20 ng/mL; R&D Systems), db-
cAMP (0.1 mM; Sigma) and kanamycin/gentamycin (Sigma).
Residual fibroblasts were removed by negative immunopanning
on dishes coated with Thy1.1 antibodies as described previously
(Mathon et al. 2001). Murine Schwann cells were subcultured
up to a maximum of four times prior to coculture with DRGs
(see below).
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DRG preparation
For association assays and rat dissociation assays, DRGs were
dissected from P0–P1 Sprague-Dawley rats and explanted on
poly-L-lysine and laminin-coated coverslips in defined medium
(DMEM/F12; Invitrogen) supplemented with 100 ng/mL NGF
(Alamone Laboratories), Transferrin, SATO supplement, insu-
lin (Sigma), and penicillin/streptomycin (Invitrogen). DRGs
were treated with arabinosylcytosine for 48 h to remove endog-
enous glia and fibroblasts and used 24–72 h later for coculture.
DRG cocultures
For association assays, 1.5 × 104 Schwann cells were seeded
onto DRGs in defined medium and cocultures were fixed and
stained 7–8 h later. NSRafER were pretreated with vehicle or
tamoxifen for 24 h prior to association assays. For all experi-
ments, data represent mean ± SE of duplicate cultures, and shown
is one representative experiment of three that gave similar re-
sults. For rat dissociation assays, 1.5 × 104 perineurial fibro-
blasts were first seeded onto DRGs and 24 h later Schwann cells
were added to the cocultures as above. After 3 d, cultures were
treated with vehicle (ethanol) or tamoxifen for 27 h, fixed, and
stained. For BrdU assays, 3 × 104 cells were seeded onto bare
DRGs in defined medium. Five days later serum was added O/N
and BrdU added for 8 h the following day. Cells were fixed and
costained for axons and BrdU. Cells treated with siRNA were
transfected on day 4.
Mouse dissociation assays
Orthotypic cultures were established from E13 NF1flox/flox
DRGs as follows. Dissected DRGs were dissociated in 0.1%
trypsin (Invitrogen) for 20 min, resuspended in culture medium
consisting of neurobasal medium supplemented with 10%
horse serum, B27 (Invitrogen), and NGF and plated at a density
of 1.5 × 104 cells onto poly-L-lysine and laminin coated cover-
slips. After 5–7 d, cultures were infected with adeno-GFP or
adeno-CRE viruses and processed for immunostaining 3–6 d
later.
Schwann cell infections
The Val12 mutant H-Ras cDNA in the retrovirus pinco-GFP
was a kind gift of Dr. Pier Giuseppe Pelicci. Retroviral trans-
ductions of normal rat Schwann cells to generate NS-Ctl and
NS-RasV12 cells were as described previously (Mitchell et al.
2003). NS-Ctl and NS-RasV12 cells were used for association
assays 24 h post-infection. GFP and CRE-encoding adenoviruses
were a kind gift of Dr. Axel Behrens. Adenoviral supernatants
were prepared as described in the manufacturer’s instructions
(Vivapure-VivaScience) and added at a multiplicity of infection
of ∼80 to purified NF1flox/flox Schwann cells or NF1flox/flox or-
thotypic cultures in the appropriate growth medium supple-
mented with 2 µM forskolin. Twenty-four hours later the ad-
enoviral supernatant was removed, and the medium changed to
fresh growth medium. Infection conditions were optimized to
achieve maximal infection efficiency as judged by the percent-
age of GFP-positive cells (>95%) and minimal cell toxicity.
Immunofluorescence and Western blotting
Cocultures were fixed with 4% formaldehyde for 25 min, per-
meabilized with 95% ice-cold methanol/5% acetone blocked in
3% BSA, and incubated with primary antibodies for 2 h followed
by incubation with FITC- or Texas Red-conjugated secondary
antibodies (Alexa) for 1 h. Nuclei were counterstained with
DAPI and coverslips mounted in VectaShield (Vector Laborato-
ries). Primary antibodies were anti-RT97 (1:400; kind gift of
John Woods), anti-S100 (1:400; DAKO), and anti-p75NGFR
(1:300; Chemicon). For staining of mouse cocultures, incuba-
tion with p75NGFR antibody was performed prior to permeabi-
lization. For staining of NS-Ctl and NS-RasV12-DRG cocul-
tures, permeabilization with 0.5% Triton X for 10 min instead
of methanol/acetone was used to preserve endogenous GFP
fluorescence of infected cells. Schwann cell–axonal interactions
were quantified visually by epifluorescence microscopy. For
each experimental condition a minimum of 400 cells were ran-
domly chosen from duplicate cultures and scored according to
the criteria described in the results. All scoring was performed
blind. Data are expressed as mean ± SE and P values were cal-
culated by Student t test. Western blots of mouse and rat NF1
used Santa-Cruz Biotechnologies antibody sc-67 (1:500) and of
GFP used Roche antibody (1:4000). Cellular fractionation was
performed as reported previously (Hase et al. 2005).
Quantitative real-time PCR
Total RNA was obtained using the RNeasy Plus Minikit (Qia-
gen) and 1 µg of RNA was then reverse transcribed with Super-
Script II Reverse Transcriptase (Invitrogen). Quantitative PCR
was performed using the DyNAmo SYBR Green qPCR Kit
(Finnzymes) and the Opticon 2 DNA engine (MJ Research). In-
tron-spanning gene-specific primer pairs were designed using
the Primer3 algorithm (Rozen and Skaletsky 2000) and relative
expression values for each gene of interest were obtained by
normalizing to GAPDH.
RNAi and transfections
siRNA duplexes were prepared according to the manufacturer’s
instructions (Qiagen) and specific knockdown conditions were
optimized for each target gene in primary rat Schwann cells
using the HiPerfect transfection reagent (Qiagen). Depending on
the gene of interest, a final concentration of 1 to 5 nM duplex
was used to achieve knockdown as assessed by quantitative
PCR. FuGene 6 (Roche) was used according to manufacturer’s
instructions for all transient transfections.
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